Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.
To investigate the genetic stability of vaccinia virus DNA, we have tested whether alterations occurred in the polypeptide composition of this complex virus during persistent infections. We found that variants isolated at various passages in Friend erythroleukemia cells persistently infected with vaccinia virus contained, in addition to an 8-megadalton (MDa) deletion on the left terminus of the viral genome, major alterations in the sizes of three structural proteins with molecular masses of about 39, 21, and 14 kDa. Alterations in isoelectric points were also observed in proteins of 48, 27, and 14 kDa. The 14-kDa protein is part of the virus envelope, and the variants increased the size of this protein from 0.5 to 3 kDa with increasing passage number. Alteration in size of the 14-kDa protein is a dominant trait since it appeared in the whole virus population by passage 48. With more passages, some variants were found to increase or decrease the size of a 39-kDa core protein by about 2 kDa and to decrease the size of an envelope protein of 21 kDa by about 2 kDa. These three proteins were immunogenic in mice and elicited a strong host immune response. Major alterations in the sizes of these proteins were prevented by continuous treatment of the persistently infected cultures with interferon. However, after interferon was removed, protein modifications appeared with increasing passage number. Generation of the 8-MDa deletion and alterations in the size of the 14-kDa protein correlated with a marked decrease in virulence of these variants. Our findings suggest that during virus persistence, specific mutations are introduced in the vaccinia virus genome that lead to protein alterations and to highly attenuated viruses.
D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D002478:Cells, Cultured; D004279:DNA, Viral / Q000235:genetics; D005814:Genes, Viral; D007526:Isoelectric Point; D004915:Leukemia, Erythroblastic, Acute / Q000382:microbiology; D051379:Mice; D008970:Molecular Weight; D009154:Mutation; D013997:Time Factors; D014615:Vaccinia / Q000382:microbiology*; D014616:Vaccinia virus / Q000472:pathogenicity* / Q000502:physiology; D014764:Viral Proteins / Q000276:immunology / Q000502:physiology*
D000956:Antigens, Viral; D004279:DNA, Viral; D014764:Viral Proteins